A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans

Nat Commun. 2014 Sep 16:5:4871. doi: 10.1038/ncomms5871.

Abstract

The analysis of rich catalogues of genetic variation from population-based sequencing provides an opportunity to screen for functional effects. Here we report a rare variant in APOC3 (rs138326449-A, minor allele frequency ~0.25% (UK)) associated with plasma triglyceride (TG) levels (-1.43 s.d. (s.e.=0.27 per minor allele (P-value=8.0 × 10(-8))) discovered in 3,202 individuals with low read-depth, whole-genome sequence. We replicate this in 12,831 participants from five additional samples of Northern and Southern European origin (-1.0 s.d. (s.e.=0.173), P-value=7.32 × 10(-9)). This is consistent with an effect between 0.5 and 1.5 mmol l(-1) dependent on population. We show that a single predicted splice donor variant is responsible for association signals and is independent of known common variants. Analyses suggest an independent relationship between rs138326449 and high-density lipoprotein (HDL) levels. This represents one of the first examples of a rare, large effect variant identified from whole-genome sequencing at a population scale.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • Alternative Splicing
  • Apolipoprotein C-III / genetics*
  • Child
  • Female
  • Gene Frequency
  • Humans
  • Lipoproteins, HDL / blood
  • Lipoproteins, VLDL / blood*
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Triglycerides / blood*
  • Twins / genetics
  • White People

Substances

  • Apolipoprotein C-III
  • Lipoproteins, HDL
  • Lipoproteins, VLDL
  • Triglycerides